EVMN
Evommune, Inc.
9.70$
+3.0%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2023 | 2024 | 2025 |
|---|---|---|---|
| -599.4% | -831.4% | -588.0% | |
| 20.0% | 18.4% | 10.7% | |
| – | – | 45.0% | |
| 66.9% | 106.1% | -31.7% | |
| 2.4% | 1.3% | 1.8% | |
| -968.7% | -57.0% | -887.0% | |
| – | – | -2.9% | |
| 1,275.1% | 706.0% | 1,698.2% | |
| 580.5% | -182.4% | 213.9% | |
| -601.8% | -832.6% | -589.8% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.